Co., Oklahoma City, OK). Cells were cultured in HB101 culture medium (Hana Biologics Inc., Alemeda, CA) supplemented with penicillin G (100 U/ml), streptomycin (100 fag/ml) (Sigma Chemical CO.), L-glutamine (2 mM/liter) (Gibco Laboratories), sodium pyruvate (10 mM/liter), and Hepes (10 mM/liter) .
PBMC (1 .5 x 106 in 1 ml) were cultured in 48-well culture plates (Costar, Cambridge, MA) in a humidified atmosphere of 5% C02 and 95% air. Culture supernatants from mitogen-stimulated cells (PHA 1% ; PWM 1% ; vol/vol) were harvested after 3 d. Two-way mixed lymphocyte cultures (MLC), containing equal numbers ofPBMC from two unrelated donors, were harvested after 6 d, except when otherwise indicated.
RIAs. The IFN-,y levels in cell-free culture supernatants were detected by a commercially available solid-phase RIA kit (Centocor Co., Malvern, PA) . IgE was measured by a solid-phase RIA using two mAbs, exactly as previously described (9) . The net synthesis of IgE and ofIFN-,y was determined by substracting the values measured in the culture supernatants of cycloheximide-treated cells from those of untreated cells .
Northern Blot Analysis. Total cytoplasmic RNA was purified from 107 MLR mononuclear cells by this guanidine-thiocyanate method (10) and subjected to electrophoresis on a formaldehyde-denaturing agarose gel . After transfer to a nitrocellulose membrane (Schleicher & Schuell, Inc,, Keene, NH), the samples were hybridized (11) with a 1.4-Kb nick-translated Barn HI/Bam HI fragment ofthe human IFN-,y cDNA sequence derived from pSVT69 (12) . After autoradiography, the IFN-,y probe was washed off and the membrane was rehybridized with a human y-actin cDNA probe .
Results
In the course of our studies on the regulation of IgE synthesis by PBMC from healthy adults, we noticed that IL-4 not only triggered the synthesis of IgE but also suppressed the production of IFN-y by these cells. In 21 consecutive experiments where the levels of IFN-y in the unstimulated cultures ranged from 5 to 45 U/ml, IL-4 induced a suppression ranging from 70 to 100%. These observations prompted us to examine the effect of IL-4 on the synthesis of IFN-,y by PBMC stimulated with mitogens or with allogeneic cells. The data in Tables I and II trations of PWM, PHA, or by allogeneic cells. This effect was blocked by a neutralizing mAb to IL-4. In all these experiments, IL-4 was used at a concentration of 300 U/ml, which is optimal for the induction ofIgE synthesis. However, the IL-4-induced suppression of IFN-.y is dose dependent. In the representative experiment shown in Fig. 1 , increasing concentrations of IL-4 were added to a MLC. As seen, IL-4 had a reciprocal and dose-dependent effect on the synthesis ofboth IFN-T and IgE. The IgE levels were low due to the short duration (6 d Dose-dependent effect of IL-4 on the synthesis of IFN-y and IgE during MLC. MLC was performed as described in Materials and Methods. IL-4, at the indicated concentrations, was added at the start of the cultures . Culture supernatant was harvested after 6 d. After normalization according to the human -y-actin mRNA level, which was not influenced by IL-4 treatment, the accumulative IFN-y mRNA level displayed an inhibition of 75 % (as determined by densitometer scanning) in the presence of 300 U/ml IL-4 (data not shown) . Discussion Our observations demonstrate that IL-4 inhibits the in vitro production of IFN-'r by human PBMC. The suppression is observed both at the protein and at the mRNA level; it is dose and time dependent, and it is blocked by a neutralizing mAb to IL-4. The dose-response and the kinetic studies confirm the prevalent concept of an inverse relationship between the production of IgE and of IFN-y.
The data from the time course experiments may further suggest that the selection of the IgE isotype expression occurs early in the course of an immune response. Indeed, IL-4 has to be present at the initiation ofthe lymphocyte activation in order to exert its maximal suppressive effect on the production of IFN-y, indicating that, when lymphocytes are activated in such a way that IL-4 is produced first, this would prevent the subsequent production of IFN-y. Therefore, the balance between these two antagonistic lymphokines may be significantly influenced by the chronological order of activation of their respective gene.
We are currentlyinvestigating the molecular mechanism ofthese observations and we are testing whether the IL-4-induced inhibition of the accumulation of IFN-yspecific mRNA in allogeneic stimulated cells is due to a reduced transcription rate or to an increased mRNA degradation.
The observed effect of IL-4 cannot be attributed to inhibition of the lymphocyte activation, since the addition ofIL-4 to cells stimulated by mitogens or by allogeneic cells enhanced the DNA synthesis, as measured by [3H]thymidine uptake (data not shown) .
IL-2 has been reported to increase the production of IFN-'r by T cells stimulated with mitogens or antigen (13) . We observed that IL-4 still suppressed the IFN-y production in MLR cultures supplemented with IL-2 (data not shown) . This indicates that the IL-4 effect is not due to the inhibition of the IL-2-mediated IFN-'r induction.
The suppressive activity of IL-4 on the production of IFN-y might occur in vivo as well . Indeed, in a recent study on murine Leishmaniasis, Heinzel et al. (14) reported that susceptible strains of mice (BALB/c) express high tissue levels of IL-4 mRNA and low levels ofIFN-y mRNA, whereas the resistant C57BL/6 strain expresses high levels of IFN-'Y and low levels of IL-4. As expected, BALB/c mice display a strong IgE response after Leishmania infection, whereas C57BL/6 do not. IFN-y was shown to play a critical role in the resistance to this parasite (15, 16) . Relevant to the present data is the observation that treatment of susceptible mice with anti-IL-4 mAb significantly enhanced their resistance to the parasite. As suggested by the authors, this might be due to the neutralization of the harmful effects ofIL-4 in this infection or to the restoration of IFN-y production . The latter possibility is supported by the present observations that IL-4 suppresses the production of IFN-y .
Since IFN-y plays a key role in protective immunity against several pathogens with an obligatory or facultative intracellular cycle, the observation that IFN-y production is suppressed by IL-4 may be relevant in clinical conditions where an increased IgE production (as a marker of high IL-4 and low IFN-y production) is associated with either chronic parasitic disease or increased susceptibility to infections . Summary rIL-4 inhibits the production of IFN-y by PBMC stimulated with mitogens or allogeneic cells. The suppression is observed at the protein and at the mRNA level; it is dose and time dependent, and it is abolished by a neutralizing mAb to IL-4. It is suggested that the balance between the production of IL-4 and IFN-'r may be significantly influenced by the chronological order of activation oftheir respective gene.
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